| |
| |
|
| Insider
Information: |
Yeramian Patrick D |
| Relationship: |
|
| City: |
Boca Raton |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
205,605 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
205,605 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-01-09 |
205,605 |
2022-01-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2024-01-09 |
4 |
S |
$16.33 |
$45,915 |
D/D |
(2,812) |
205,605 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-05-15 |
4 |
AS |
$29.03 |
$347,358 |
D/D |
(11,965) |
208,417 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-05-15 |
4 |
OE |
$0.37 |
$67,991 |
D/D |
11,965 |
220,382 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-04-17 |
4 |
AS |
$30.53 |
$1,513,942 |
D/D |
(49,579) |
208,417 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-04-17 |
4 |
OE |
$0.37 |
$49,058 |
D/D |
49,579 |
257,996 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-03-16 |
4/A |
A |
$0.00 |
$0 |
D/D |
9,167 |
208,417 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-03-16 |
4/A |
AS |
$31.85 |
$1,741,200 |
D/D |
(54,627) |
199,250 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-03-16 |
4/A |
OE |
$0.33 |
$127,262 |
D/D |
49,578 |
253,877 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,167 |
158,839 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-03-16 |
4 |
AS |
$31.85 |
$1,741,200 |
D/D |
(54,627) |
149,672 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2023-01-06 |
4 |
S |
$36.08 |
$73,831 |
D/D |
(2,034) |
204,299 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Medical Officer |
• – – |
2022-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,333 |
206,333 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
